ClinicalTrials.Veeva

Menu

Physical Exercise in OCD: Treatment Efficacy, Additive Benefits to CBT, and Cognitive Correlates of Change

S

Sunnybrook Health Sciences Centre

Status

Completed

Conditions

Obsessive-Compulsive Disorder
Cognition Disorders

Treatments

Behavioral: Exercise
Behavioral: Cognitive Behavioural Therapy (CBT)

Study type

Interventional

Funder types

Other

Identifiers

NCT02136953
MOP133452

Details and patient eligibility

About

Obsessive compulsive disorder (OCD) is a severe and debilitating anxiety disorder afflicting 2% of the population. Cognitive behavioural therapy (CBT) is considered first line psychological treatment for OCD, but there are a large number of treatment non-responders, and the majority of responders have residual symptoms. Aerobic exercise has shown potential benefit for general mood and anxiety disorders, but has not been widely tested in OCD. This study will examine the additive benefits of a standard 12-week aerobic exercise program to a standard 12-week CBT protocol in the treatment of OCD. The study will test if Exercise+CBT results in significantly better clinical outcomes compared to either treatment alone or no treatment at all. Treatment outcomes will be assessed in relation to symptom and cognitive measures of clinical improvement.

Full description

This study aims to determine if a standard, evidence-based 12-week aerobic exercise program results in significant reduction of obsessive-compulsive symptom severity and associated cognitive dysfunction as a stand-alone intervention and when combined with the first-line psychological treatment, cognitive behavioural therapy (CBT). There are 3 broad aims to this study: 1) to compare the relative efficacy of Exercise, CBT, and their combination (CBT+Ex) versus a non-treatment waitlist control (WL), 2) to examine the extent to which neuropsychological features of OCD improve following treatments, and 3) to determine the extent to which the BDNF gene and protein are a) associated with learning and cognitive factors, and b) moderate symptom and cognitive change across treatments.

The study design allows for a novel, well-powered and potentially landmark study on the impact of exercise on obsessive-compulsive symptom severity and cognitive functioning in OCD, both as a stand-alone treatment and when augmenting CBT. If this study can demonstrate that a short aerobic exercise program of 12 weeks duration can confer significant clinical gains for those suffering with OCD, then it could easily be translated into highly accessible, routine clinical care. Further, demonstration of improvement in OCD-associated cognitive dysfunction, given the refractory nature of the illness, would provide another avenue into the long-term enhancement of outcomes for this chronically affected population.

Enrollment

125 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presenting with DSM-5 diagnosed OCD
  • Score of >16 on the Yale-Brown Obsessive Compulsive Scale (YBOCS)
  • A Physical Activity Readiness Questionnaire (PAR-Q) score of ≤1
  • If on medications for OCD, must be stabilized, i.e. are currently receiving an adequate dose (equivalent of 40mg/day of fluoxetine) for an adequate duration (at least 12 weeks of treatment) prior to the initiation of the study
  • Has physician letter of approval for safe participation in fitness assessment and exercise protocol

Exclusion criteria

  • Previous course of CBT treatment (≥ 8 sessions) in past two years
  • Engaging in an active exercise regimen (>2 days/wk of moderate-to-vigorous exercise training) at the time of recruitment
  • Concurrent diagnosis of a severe mood disorder, schizophrenia or other psychotic disorders, or substance abuse/dependence
  • Suspected organic pathology
  • Active comorbid medical condition that may require urgent intervention during the treatment
  • Incapable of providing informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

125 participants in 4 patient groups

Exercise
Experimental group
Description:
12-weeks of structured, individual aerobic exercise, 3 times a week, increasing from 15-30 minutes to 30-40 minutes per session.
Treatment:
Behavioral: Exercise
Cognitive Behavioural Therapy (CBT)
Active Comparator group
Description:
12-weeks of manual-based group CBT, 2 hours per week, 8 participants per group.
Treatment:
Behavioral: Cognitive Behavioural Therapy (CBT)
Exercise and CBT
Experimental group
Description:
Combined 12-week Exercise program and CBT.
Treatment:
Behavioral: Exercise
Behavioral: Cognitive Behavioural Therapy (CBT)
Waitlist Condition
No Intervention group
Description:
12-week waitlist control condition, after which participants will have the chance to receive CBT group treatment.

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems